Effect of narrowband ultraviolet B therapy on serum levels of CD26/dipeptidyl-peptidase IV and truncated forms of substance P in psoriasis patients with pruritus

References

• Yosipovitch G, Goon A, Wee J, Chan Y, Goh C. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143(5):969–973. doi:10.1046/j.1365-2133.2000.03829.x11069504
   PubMed Web of Science ®Google Scholar
• Tsianakas A, Mrowietz U. Pruritus bei Psoriasis. Der Hautarzt. 2016;67(8):601–605. doi:10.1007/s00105-016-3835-x27376751
   PubMed Web of Science ®Google Scholar
• Roblin D, Wickramasinghe R, Yosipovitch G. Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity. J Am Acad Dermatol. 2014;70(2):390–391. doi:10.1016/j.jaad.2013.09.03024438964
   PubMed Web of Science ®Google Scholar
• Reich A, Welz-Kubiak K, Rams Ł. Apprehension of the disease by patients suffering from psoriasis. Postepy Dermatol Alergol. 2014;31(5):289. doi:10.5114/pdia.2014.4401025395924
   PubMed Web of Science ®Google Scholar
• Van Lingen RG, Van De Kerkhof PCM, Seyger MMB, et al. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes. Br J Dermatol. 2008;158(6):1264–1272. doi:10.1111/j.1365-2133.2008.08515.x18384439
   PubMed Web of Science ®Google Scholar
• Komiya E, Hatano R, Otsuka H, et al. A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus. J Dermatol Sci. 2017;86(3):212–221. doi:10.1016/j.jdermsci.2017.03.00528365081
   PubMed Web of Science ®Google Scholar
• Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999;189(4):711–718. doi:10.1084/jem.189.4.7119989986
   PubMed Web of Science ®Google Scholar
• Ohnuma K, Dang NH, Morimoto C. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol. 2008;29(6):295–301. doi:10.1016/j.it.2008.02.01018456553
   PubMed Web of Science ®Google Scholar
• Drucker DJ. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care. 2003;26(10):2929–2940. doi:10.2337/diacare.26.10.292914514604
   PubMed Web of Science ®Google Scholar
• Brodin E, Gazelius B, Panopoulos P, Olgart L. Morphine inhibits substance P release from peripheral sensory nerve endings. Acta Physiol Scand. 1983;117(4):567–570. doi:10.1111/j.1748-1716.1983.tb07228.x6192685
   PubMedGoogle Scholar
• Duffy RA. Potential therapeutic targets for neurokinin-1 receptor antagonists. Expert Opin Emerg Drugs. 2004;9(1):9–21. doi:10.1517/eoed.9.1.9.3295615155133
   PubMedGoogle Scholar
• Nadel JA. Mechanisms of inflammation and potential role in the pathogenesis of asthma. Allergy Asthma Proc. 1991;12(2):85–88. OceanSide Publications. doi:10.2500/108854191779011774
   Web of Science ®Google Scholar
• Koch TR, Carney JA, Go LWV. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci. 1987;32(4):369–376. doi:10.1007/bf012962902435473
   PubMed Web of Science ®Google Scholar
• Szepietowski JC, Reich A, Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10(4):221–226.12588672
   PubMedGoogle Scholar
• Dawn A, Yosipovitch G. Treating itch in psoriasis. Dermatol Nurs. 2006;18(3):227.16856675
   PubMedGoogle Scholar
• Wiśnicka B, Szepietowski J, Reich A, Orda A. Histamine, substance P and calcitonin gene-related peptide plasma concentration and pruritus in patients suffering from psoriasis. Dermatol Psychosom. 2004;5(2):73–78. doi:10.1159/000079211
   Google Scholar
• Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk JHH. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol. 1986;15(3):504–507. doi:10.1016/s0190-9622(86)70201-63760276
   PubMed Web of Science ®Google Scholar
• Ellis CN, Berberian B, Sulica VI, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol. 1993;29(3):438–442. doi:10.1016/0190-9622(93)70208-b7688774
   PubMed Web of Science ®Google Scholar
• Proost P, De Meester I, Schols D, et al. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-Infection. J Biol Chem. 1998;273(13):7222–7227. doi:10.1074/jbc.273.13.72229516414
   PubMed Web of Science ®Google Scholar
• Bock O, Kreiselmeyer I, Mrowietz U. Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis. Exp Dermatol. 2001;10(6):414–419.11737260
   PubMed Web of Science ®Google Scholar
• Yıldırım FE, Karaduman A, Pinar A, Aksoy Y. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy. Int J Dermatol. 2011;50(8):948–955. doi:10.1111/j.1365-4632.2010.04799.x21781066
   PubMed Web of Science ®Google Scholar
• Mrowietz U, Chouela E, Mallbris L, et al. Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study. J Eur Acad Dermatol Venereol. 2015;29(6):1114–1120. doi:10.1111/jdv.1276125376448
   PubMed Web of Science ®Google Scholar
• Narbutt J, Olejniczak I, Sobolewska-Sztychny D, et al. Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res. 2013;305(3):191–195. doi:10.1007/s00403-012-1293-623108364
   PubMed Web of Science ®Google Scholar
• Legat FJ, Griesbacher T, Schicho R, et al. Repeated subinflammatory ultraviolet B irradiation increases substance P and calcitonin gene-related peptide content and augments mustard oil-induced neurogenic inflammation in the skin of rats. Neurosci Lett. 2002;329(3):309–313. doi:10.1016/s0304-3940(02)00428-712183038
   PubMed Web of Science ®Google Scholar